Copyright & Licensing
Authors retain ownership while maximizing cancer research distribution.
Your Research, Your Rights
JN embraces true Open Access philosophy. Authors retain full copyright to their work while granting the world permission to read, share, and build upon published oncology research without barriers that delay patient benefit.
Attribution License
- Authors retain full copyright ownership
- Unrestricted sharing and distribution
- Adaptation and remix permitted
- Commercial use allowed
- Proper attribution required
- Maximum cancer research impact
Copyright Retention
You do not transfer copyright to the journal. You remain the legal owner of your intellectual property and retain control of all rights not explicitly licensed.
Reuse Freedom
Use your figures, protocols, and data in grant applications, presentations, future publications, and educational materials without seeking journal permission.
Sharing Encouraged
Post the final published PDF on personal websites, institutional repositories, ResearchGate, and social media to maximize visibility across the oncology community.
Clinical Guidelines
Your work can be freely incorporated into clinical practice guidelines, educational curricula, and treatment protocols accelerating translation to patient care.
Cancer Research Funder Compliance: CC BY 4.0 licensing satisfies all major oncology funder mandates including NCI, NIH, CRUK, and Plan S requirements for immediate Open Access distribution of cancer research.
Publish Your Cancer Research Open Access
Retain ownership while reaching oncologists and patients worldwide.
